Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Marketable Securities: ¥1,345 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688513 Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
94 GF Score
Price ¥44.30
GF Value ¥46.60
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Chengdu Easton Biopharmaceuticals Co Marketable Securities?

Chengdu Easton Biopharmaceuticals Co SHSE:688513 +0.52% 94 Marketable Securities is ¥1,345 Mil as of Jun. 2026. GuruFocus rates SHSE:688513 with a GF Score™ of 94/100 and a GF Value™ of ¥46.60 (Fairly Valued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Chengdu Easton Biopharmaceuticals Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥1,345 Mil.

Chengdu Easton Biopharmaceuticals Co's annual Marketable Securities declined from Dec. 2023 (¥742 Mil) to Dec. 2024 (¥452 Mil) but then increased from Dec. 2024 (¥452 Mil) to Dec. 2025 (¥758 Mil).

Chengdu Easton Biopharmaceuticals Co  (SHSE:688513) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Chengdu Easton Biopharmaceuticals Co Marketable Securities Related Terms

Chengdu Easton Biopharmaceuticals Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengdu Easton Biopharmaceuticals Co Marketable Securities Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 453.84 516.36 741.78 452.35 758.01

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 730.16 981.76 758.01 1,295.52 1,344.52
SHSE:688513
94GF Score
Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chengdu Easton Biopharmaceuticals Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥1,345 Mil mean?
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) has a Marketable Securities of ¥1,345 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors.
Is Chengdu Easton Biopharmaceuticals Co's Marketable Securities too high?
Chengdu Easton Biopharmaceuticals Co's current Marketable Securities is ¥1,345 Mil. Overall, Chengdu Easton Biopharmaceuticals Co has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chengdu Easton Biopharmaceuticals Co's Marketable Securities compare to VRTX and REGN?
Chengdu Easton Biopharmaceuticals Co's Marketable Securities of ¥1,345 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. Chengdu Easton Biopharmaceuticals Co's current Marketable Securities is ¥1,345 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengdu Easton Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co (SHSE:688513) is currently considered Fairly Valued. The stock's GF Value™ is ¥46.60, compared to a current price of ¥44.30 — trading 4.9% below its estimated fair value. The current Marketable Securities is ¥1,345 Mil. Chengdu Easton Biopharmaceuticals Co's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Chengdu Easton Biopharmaceuticals Co (SHSE:688513), the current Marketable Securities is ¥1,345 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?

Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be undervalued. The current stock price of ¥44.30 is trading 4.9% below its estimated GF Value™ of ¥46.60. GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:688513:

  • Marketable Securities: ¥1,345 Mil
  • GF Value™: ¥46.60 vs. price of ¥44.30 (4.9% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chengdu Easton Biopharmaceuticals Co Business Description

Address No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
94GF Score

Get the complete analysis for SHSE:688513

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥44.30
Price
¥46.60
GF Value